medicine×リボミック - List of Manufacturers, Suppliers, Companies and Products

medicine Product List

1～2 item / All 2 items

Displayed results

Exudative Age-related Macular Degeneration Clinical Trial

RBM-007 is considered a potential new treatment for wet AMD patients with no prior treatment history!

We would like to introduce the clinical trials conducted by our company. As a clinical trial targeting exudative age-related macular degeneration (wet AMD), a Phase 2 clinical trial was conducted in the United States after the implementation of a Phase 1/2a clinical trial, aimed at confirming the clinical proof of concept (POC) of multiple administrations of RBM-007. Furthermore, a physician-led clinical trial was conducted in the United States to evaluate the efficacy and safety of RBM-007 monotherapy in treatment-naive wet AMD patients. 【Main Trials】 ■ Randomized double-blind trial ■ Open-label trial ■ Physician-led clinical trial *For more details, please refer to the PDF materials or feel free to contact us.

Company：リボミック
Price：Other

Other Testing Contract

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Clinical Trial: Achondroplasia

RBM-007 strongly suggests that it could be a new drug for cartilage dysplasia!

We would like to introduce the clinical trials conducted by our company. The project concerning achondroplasia received support from the Japan Agency for Medical Research and Development (AMED) and began a Phase 1 trial in July 2020 at a domestic clinical trial facility to investigate the safety, tolerability, and pharmacokinetics of RBM-007, which was conducted until May 2021. Regarding the Phase 2 trial of this project, it has been adopted as a pre-commercialization support project for orphan drugs by AMED for three years starting from the fiscal year 2021. [Main Trials] ■ Phase 1 Clinical Trial ■ Early Phase 2 Observational Trial ■ Early Phase 2 Clinical Trial ■ Early Phase 2 Long-term Clinical Trial *For more details, please refer to the PDF materials or feel free to contact us.